Get the Stockscreener App
39.44
0.73%
-0.29
After Hours:
39.44
Conmed Corp stock is traded at $39.44, with a volume of 371.35K.
It is down -0.73% in the last 24 hours and up +5.79% over the past month.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
See More
Previous Close:
$39.73
Open:
$39.73
24h Volume:
371.35K
Relative Volume:
0.73
Market Cap:
$1.19B
Revenue:
$1.37B
Net Income/Loss:
$47.06M
P/E Ratio:
26.03
EPS:
1.5151
Net Cash Flow:
$150.88M
1W Performance:
+7.79%
1M Performance:
+5.79%
6M Performance:
-11.33%
1Y Performance:
-18.66%
1-Day Range:
$39.10
$40.03
1-Week Range:
$35.98
$40.03
52-Week Range:
$33.21
$61.08
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
39.44 | 1.20B | 1.37B | 47.06M | 150.88M | 1.5151 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-12-25 | Downgrade | Needham | Buy → Hold |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
Here's why you should retain CONMED stock in your portfolio now - MSN
A Look at Conmed Corp (CNMD) After 3.3% Gain -- GF Value $78.09 vs Price $39.73 - GuruFocus
CONMED (NYSE:CNMD) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
SG Americas Securities LLC Sells 51,018 Shares of CONMED Corporation $CNMD - MarketBeat
Guidance Update: Can CONMED Corporation keep up with sector leaders2026 Trading Volume Trends & Trade Opportunity Analysis - baoquankhu1.vn
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Yahoo Finance
Tudor Investment Corp ET AL Boosts Stock Position in CONMED Corporation $CNMD - MarketBeat
CONMED Corporation (CNMD) Stock Forecasts - Yahoo Finance
Form DEF 14A CONMED Corp For: May 18 - StreetInsider
[ARS] CONMED Corp SEC Filing - Stock Titan
Board moves, CEO pay and buybacks at CONMED (NYSE: CNMD) - Stock Titan
CONMED Corporation (CNMD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Allspring Global Investments Holdings LLC Grows Stake in CONMED Corporation $CNMD - marketbeat.com
Guidance Update: Whats the analyst consensus on CONMED Corporation2026 Short Interest & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Could CONMED’s Q4 Beat and Q1 Preview Reframe Its Margin Narrative for CNMD Investors? - Yahoo Finance
Is It Time To Revisit CONMED (CNMD) After A 37% One Year Share Price Slide? - Yahoo Finance
CNMD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CNMD SEC FilingsConmed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
CONMED (CNMD) CEO Pat Beyer awarded $1M in RSUs vesting over 3 years - Stock Titan
CONMED schedules April 29 earnings release, 4:30 p.m. call - Stock Titan
Conmed Corp (EC8.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
CNMD PE Ratio & Valuation, Is CNMD Overvalued - Intellectia AI
CONMED Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
CONMED Corp. Stock Plummets to New 52-Week Low of $34.54 - Markets Mojo
Published on: 2026-03-31 05:24:09 - baoquankhu1.vn
CONMED (NYSE:CNMD) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
CONMED (NYSE:CNMD) Sets New 12-Month LowTime to Sell? - marketbeat.com
Does CONMED Corporation have declining or rising EPS2026 Levels & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Conmed Corporation stock hits 52-week low at 35.34 USD - Investing.com
Responsive Playbooks and the CNMD Inflection - Stock Traders Daily
Aug Mood: What are the future prospects of CONMED Corporation2026 Technicals & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
[SCHEDULE 13G/A] CONMED Corp Amended Passive Investment Disclosure - Stock Titan
Are Options Traders Betting on a Big Move in CONMED Stock? - Yahoo Finance
Tudor Investment Corp ET AL Acquires 83,418 Shares of CONMED Corporation $CNMD - MarketBeat
Movement Recap: Can CONMED Corporation sustain its profitability2026 Technical Patterns & AI Powered Market Entry Strategies - baoquankhu1.vn
CONMED Taps Andrew Moller As Interim Finance Chief In Demand Slump - Yahoo Finance
CONMED (NYSE:CNMD) Strengthens Role In Nyse Composite Landscape - Kalkine Media
Is It Time To Reassess CONMED (CNMD) After A 39% One Year Share Price Slide - simplywall.st
Market Pulse: Is CONMED Corporation likely to announce a buyback2026 Breakouts & High Accuracy Investment Signals - baoquankhu1.vn
Confluence Investment Management LLC Has $3.70 Million Stake in CONMED Corporation $CNMD - Defense World
Conmed (NYSE:CNMD) Portfolio Changes Reflect Broader Market Trends Nyse Composite Today - Kalkine Media
CONMED (NYSE:CNMD) Stock Rating Upgraded by Wells Fargo & Company - Defense World
Micro-Tech Endoscopy to acquire Conmed gastroenterology products - MassDevice
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE) - The Globe and Mail
CONMED (NYSE:CNMD) Upgraded to "Hold" at Wells Fargo & Company - MarketBeat
CONMED (NYSE: CNMD) EVP granted 17,198 RSUs after award correction - Stock Titan
CONMED (NYSE: CNMD) VP granted 17,471 RSUs under 2025 incentive plan - Stock Titan
CONMED (CNMD) grants 18,563 RSUs to its general counsel Foust - Stock Titan
Executive VP at CONMED (CNMD) awarded 16,926 RSUs in corrected Form 4/A - Stock Titan
[Form 4/A] CONMED Corp Amended Insider Trading Activity - Stock Titan
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):